Obstructive Sleep Apnea and Circadian Rhythm Sleep Disorders - A Best Practices Report From the Cases & Commentary Workshop
- Credit Type
- CME
- Credit Amount
- 1
- Release Date
- 02/16/2010
- Expiration Date
- 02/15/2011
- Activity Type
- Monograph
Jointly sponsored by Albert Einstein College of Medicine, Montefiore Medical Center, and Asante Communications
This activity is supported by an educational grant from Cephalon, Inc.
Release Date: 2/16/10
Expiration Date: 2/15/11
Activity Goal
This monograph highlights scienti fic and clinical data that promote best practices in the individualized assessment and management of patients with sleep/wake disorders.
Intended Audience
This activity is intended for sleep clinicians, primary care physicians, physician assistants, nurse practitioners, and other healthcare providers interested in improving their knowledge base and skill sets in sleep/wake medicine. There are no prerequisites for this educational activity.
Statement of Need
Characterized by their heterogeneity and profound effects on patient function, sleep/wake disorders are prevalent and often inadequately treated, resulting in significant morbidity and mortality. Healthcare-related costs are particularly burdensome, estimated at nearly USD 100 billion per annum. Data from numerous epidemiologic and randomized controlled studies clearly demonstrate that patients with disrupted sleep/wake patterns have significantly impaired function and experience excessive sleepiness, a debilitating symptom with far-reaching consequences. Furthermore, the possibility that comorbidities associated with sleep/wake disorders may not be completely reversible highlights the importance of recognizing these symptoms and consequences. Healthcare providers need to improve their understanding of the morbidity associated with sleep/wake disorders, to communicate the issues to their colleagues and their patients, and to tailor therapies accordingly.
Learner’s Gap
Sleep/wake disorders are underdiagnosed, underrecognized, and undertreated. Evidence-based discussions supported by expert clinical experience provide a scientific and clinical rationale for individualized assessment and treatment of patients with sleep/wake disorders. Emphasizing the biopsychosocial and potentially irreversible consequences of untreated disturbances in sleep/wake consolidation enables clinicians to better assess and manage sleep/wake disorders, and thereby improve patient outcomes.
Learning Objectives
At the completion of this initiative, the participants should be better prepared to:
- Discuss the morbidity associated with obstructive sleep apnea, shift work sleep disorder, and other common sleep/wake disorders across biological, psychological, and social domains
- Recognize, evaluate, and diagnose patients presenting with excessive sleepiness and signs and symptoms associated with obstructive sleep apnea, shift work sleep disorder, and other common sleep/wake disorders
- Stratify patients by risk and severity of obstructive sleep apnea and other common sleep/wake disorders and develop appropriate referral and long-term management plans
- Employ nonpharmacologic and pharmacologic treatment modalities to ameliorate underlying causes, signs, and symptoms of common sleep/wake disorders
- Monitor treatment compliance and therapeutic progress of patients with obstructive sleep apnea and other common sleep/wake disorder–related signs and symptoms
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Albert Einstein College of Medicine and Montefiore Medical Center, and Asante Communications. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Conflict of Interest Statement
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Faculty participating in this activity have reported the following disclosures:
Thomas Roth, PhD
Acorda (Consultant); Actelion (Consultant); Addrenex (Consultant); Arena (Consultant); Aventis (Grant/Research, Consultant); BTG (Consultant); Cephalon (Grant/Research, Consultant, Speakers Bureau); Eisai (Consultant); GlaxoSmithKline (Grant/Research, Consultant); Intec (Consultant); Intra-Cellular (Consultant); McNeil (Consultant); Merck (Consultant); Neurim (Consultant); Neurocrine (Grant/Research, Consultant); Otsuka (Consultant); Pfizer (Grant/Research, Consultant); sanofi-aventis (Grant/Research, Consultant, Speakers Bureau); Schering-Plough (Grant/Research, Consultant); Sepracor (Grant/Research, Consultant); Shire (Consultant); Somaxon (Grant/Research, Consultant); Syrex (Grant/Research, Consultant); Takeda (Grant/Research, Consultant, Speakers Bureau); TransOral (Grant/Research, Consultant); Wyeth (Grant/Research, Consultant); Xenoport (Grant/Research, Consultant)
Michael J. Thorpy, MD Cephalon, Inc.; Jazz Pharmaceuticals
(consultant, speakers bureau)
Andrew G. Israel, MD
sanofi-aventis (Consultant)
Andrew D. Krystal, MD, MS
Actelion (Consultant); Arena (Consultant); Astellas (Grant/Research, Consultant); AstraZeneca (Consultant); Axiom (Consultant); Bristol-Myers Squibb (Consultant); Cephalon (Grant/Research, Consultant); CHDI (Consultant); Eli Lilly (Consultant); Evotec (Consultant); GlaxoSmithKline (Consultant); Jazz (Consultant); Johnson and Johnson (Consultant); King (Consultant); Kingsdown Inc. (Consultant); Merck (Grant/Research, Consultant); Neurocrine (Grant/Research, Consultant); Neurogen (Grant/Research, Consultant); NIH (Consultant); Neuronetics (Grant/Research, Consultant), Novartis (Consultant); Organon (Consultant); Ortho-McNeil-Janssen (Consultant); Pfizer (Grant/Research, Consultant); Research Triangle Institute (Consultant); Respironics (Grant/Research, Consultant); Roche (Consultant); sanofi-aventis (Grant/Research, Consultant), Sepracor (Consultant); Somaxon (Grant/Research, Consultant); Takeda (Grant/Research, Consultant); Transcept (Grant/Research, Consultant)
One staff member at Albert Einstein College of Medicine has reported the following disclosures:
Steven Jay Feld, or a member of his household, owns securities in Bioheart, Inc.; Chelsea Therapeutics, Inc.; and Pharmacopeia, Inc.
Chris Ontiveros, PhD, (senior scientific associate, Asante Communications, LLC) has no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
Method of Participation
There are no fees for participating in and receiving credit for this activity. Participants must read the objectives and enduring material, and answer the multiple-choice posttest. Please complete the evaluation form, which enables you to comment on the quality of the instructional process, the perception of enhanced professional effectiveness and commercial bias, and express your views on future educational needs. A score of at least 70% is required to successfully complete this activity. Credit is available through February 15, 2011.
Copyright Information Privacy Policy
Please read Albert Einstein College of Medicine's Privacy Policy.
If you have questions about this CME activity, please contact Albert Einstein College of Medicine at 718-920-6674 or cme@montefiore.org.
Copyright Information
Copyright © 2010 Albert Einstein College of Medicine and Montefiore Medical Center, and Asante Communications. All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.
Privacy Policy Statement for Internet CME Activities
The below statements explains the Center for Continuing Medical Education’s online information practices to assure your privacy when participating in CME activities on the Internet.
These statements have been provided by the Center for Continuing Medical Education of the Albert Einstein College of Medicine/Montefiore Medical Center. If you have any questiosn pertaining to the Privacy Policy, please contact the Center for Continuing Medical Education directly at the address listed at the bottom of this page.
Information Collected and Purpose
Regarding visitors to the Internet site:
- We collect aggregate information on what pages are visited to assess and improve the content of the site.
- Our Web server does not automatically recognize information regarding individual users (eg, domain name or e-mail address).
- We do not set any cookies to track visitor’s identification or use of the site.
When visitors register for CME activities:
- We ask for information about their identity to maintain a record of their participation.
Additionally, when visitors participate in web-based CME activities:
- We ask participants to complete a knowledge test as part of a CME activity to provide feedback concerning the their understanding of the content.
- We ask participants to evaluate CME activities so we may improve these and future activities.
Other Uses of Information
We may use the information you provide to contact you:
- To check on potential verification problems (eg, duplicate registration for the same activity)
- To ask for more detail about information you have provided (eg, on your suggestions for improvements)
You may request that we provide you with a copy of our record of the information that you provided to use (see “Contact Information” below).
Change in Policy
If we alter our policy practices, we will modify this policy statement to reflect these changes. All subsequent changes to this program will apply to the new practices.
Security
We have appropriate security measures in place in our physical facilities to protect against the loss, misuse, or alteration of information that we have collected from you.
Concerns About Following Policy
If you feel that actions associated with this site are not consistent with this privacy policy, you may contact the CME office directly (see “Contact Information” below). Alternatively, you may contact the Center for Continuing Medical Education by e-mail at cme@montefiore.org.
Contact Information
If you have questions about this privacy policy or other questions regarding CME at the Center for Continuing Medical Education, you are welcome to contact us:
Phone: (718) 920-6674
Fax: (718) 798-2336
Email: cme@montefiore.org
Mail: Center for Continuing Medical Education
Albert Einstein College of Medicine
Montefiore Medical Center
3301 Bainbridge Avenue
Bronx, New York 10467
Faculty
